Every SEC Form 3/4/5 on record for this filer (CIK 1803806) — 30 issuers, 45 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
This filer is an entity, not a person. This reporting owner's name carries a corporate/fund legal form, so it is an ENTITY filing under Section 16 — typically a fund with a board-designation right or a 10% holder — not an individual. Its 'director' rows are the entity's designation right, not a person's board seat.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Director | 2020-08-25 → 2026-06-26 | 20 | $5M |
| OLMA | Olema Pharmaceuticals, Inc. | Director | 2020-11-19 → 2026-06-23 | 12 | — |
| MLTX | MoonLake Immunotherapeutics | Director | 2022-04-15 → 2026-06-22 | 7 | — |
| XOMA | XOMA Royalty Corp | 10% owner | 2020-03-17 → 2026-05-18 | 22 | $931,762 |
| IMUX | IMMUNIC, INC. | Director | 2026-02-27 → 2026-02-27 | 1 | — |
| RPTX | Repare Therapeutics Inc. | Filer | 2021-11-08 → 2026-01-30 | 8 | $22M |
| EPIX | ESSA Pharma Inc. | Filer | 2022-07-21 → 2025-10-14 | 3 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | Filer | 2025-06-17 → 2025-06-17 | 1 | — |
| ALLK | Allakos Inc. | Filer | 2024-01-26 → 2025-05-19 | 2 | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | Filer | 2024-12-17 → 2024-12-17 | 1 | — |
| FDMT | 4D Molecular Therapeutics, Inc. | Filer | 2022-06-27 → 2024-11-13 | 3 | — |
| THRD | Third Harmonic Bio, Inc. | Filer | 2022-12-22 → 2024-10-31 | 3 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | Filer | 2022-01-31 → 2024-10-31 | 4 | — |
| RAIN | Rain Enhancement Technologies Holdco, Inc. | Director · lapsed | 2021-04-27 → 2024-01-29 | 12 | $10M |
| PNT | POINT Biopharma Global Inc. | Filer · lapsed | 2023-11-06 → 2023-12-20 | 2 | — |
| ENGN | enGene Therapeutics Inc. | Filer · lapsed | 2023-11-13 → 2023-11-13 | 1 | — |
| CTIC | CTI BIOPHARMA CORP | Director · lapsed | 2020-03-04 → 2023-06-28 | 8 | $5M |
| PIRS | PIERIS PHARMACEUTICALS, INC. | Filer · lapsed | 2023-05-22 → 2023-05-22 | 1 | — |
| GPCR | Structure Therapeutics Inc. | Filer · lapsed | 2023-02-13 → 2023-05-12 | 2 | — |
| CGEM | Cullinan Therapeutics, Inc. | Filer · lapsed | 2022-01-10 → 2023-01-19 | 5 | $3M |
| VSTM | Verastem, Inc. | Filer · lapsed | 2022-02-07 → 2022-02-07 | 1 | — |
| MRUS | Merus N.V. | Filer · lapsed | 2020-06-03 → 2021-10-08 | 13 | $2M |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Filer · lapsed | 2020-05-18 → 2021-03-08 | 7 | $2M |
| INFI | INFINITY PHARMACEUTICALS, INC. | Filer · lapsed | 2021-01-26 → 2021-02-19 | 3 | — |
| CTMX | CytomX Therapeutics, Inc. | Filer · lapsed | 2020-12-28 → 2021-02-18 | 2 | — |
| IDYA | IDEAYA Biosciences, Inc. | Filer · lapsed | 2020-06-22 → 2021-02-04 | 4 | — |
| NVUS | Eledon Pharmaceuticals, Inc. | Filer · lapsed | 2020-10-05 → 2020-12-28 | 2 | — |
| CYTK | CYTOKINETICS INC | Filer · lapsed | 2020-11-16 → 2020-12-11 | 4 | — |
| GLYC | GLYCOMIMETICS INC | Filer · lapsed | 2020-11-03 → 2020-11-06 | 2 | — |
| PRNB | Principia Biopharma Inc. | Filer · lapsed | 2020-08-20 → 2020-08-20 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KYMR | 2023-11-03 | Buy | 83,708 | $14.07 | $1M | 2,104,075 |
| KYMR | 2023-11-03 | Buy | 103,885 | $14.07 | $1M | 2,656,191 |
| KYMR | 2023-11-03 | Buy | 10,106 | $14.07 | $142,191 | 294,632 |
| KYMR | 2023-11-02 | Buy | 26,772 | $11.64 | $311,626 | 284,526 |
| KYMR | 2023-11-02 | Buy | 132,016 | $11.64 | $2M | 2,020,367 |
| KYMR | 2023-11-02 | Buy | 57,618 | $11.64 | $670,674 | 2,552,306 |
| RAIN | 2022-11-08 | Buy | 970,171 | $5.83 | $6M | 2,870,985 |
17 of 30 issuers are covered and open a security page; the rest are on file here only.
